Evidence map›Paper›PMID 29264512›Full record

ReviewJournal of the Endocrine Society2017

Management of Asymptomatic Patients With Positive Coronary Artery Calcium Scans.

Mark R Burge, R Philip Eaton, George Comerci, Brendan Cavanaugh, Barry Ramo, David S Schade

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of the Endocrine Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Coronary Artery Calcium Scoring in Asymptomatic Patients.HCA healthcare journal of medicine · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mark R BurgeDivision of Endocrinology, DoIM, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131.
R Philip EatonDivision of Endocrinology, DoIM, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131.
George ComerciDivision of General Medicine, DoIM, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131.
Brendan CavanaughNew Mexico Heart Institute, Albuquerque, New Mexico 87102.
Barry RamoNew Mexico Heart Institute, Albuquerque, New Mexico 87102.
David S SchadeDivision of Endocrinology, DoIM, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe widespread availability of the coronary artery calcium scan to diagnose coronary artery atheroma semiquantitatively and its prognostic significance has frequently resulted in a difficult therapeutic decision for physicians caring for asymptomatic patients. PATIENTS AND RISK FACTORS: Of particular concern are patients over 40 years of age and young adults characterized by multiple cardiovascular risk factors. The correct prognostic interpretation of coronary artery calcium scores and the potential benefits and risks of various therapeutic modalities need to be understood.

conclusionThis review describes the therapeutic choices available to endocrinologists and provides recommendations for various treatment options.

Indexed as

calcium scancoronary angiographyheart diseaseLDL cholesterolstatinsstress testing

Identifiers

PMID29264512
PMCPMC5689148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.